Scientific Laboratory Supplies (SLS) has recently been accredited as a Living Wage Employer. The Living Wage commitment will see everyone working at SLS receive a minimum hourly wage of £9.50 in the UK, or £10.85 in London. Both rates are significantly higher than the government minimum for over 25s, which currently stands at £8.72 per hour...
A shortlist of eye-catching images and videos has been drawn up for the RMS Scientific Imaging Competition – featuring as part of mmc2021. As a ‘sneak preview’, the RMS has put together a collage of all the shortlisted entries across the different categories (excluding video entries) ahead of mmc2021. The images and videos will be uploaded to an online gallery available to view from the start of the event...
In 2021, Eppendorf AG, the Hamburg life sciences company, is presenting its highly prestigious research prize for the 26th time. The independent Eppendorf Award Jury chaired by Prof. Reinhard Jahn announced Dr. Tanmay Bharat, Sir William Dunn School of Pathology, University of Oxford, United Kingdom as the winner of the Eppendorf Award for European Investigators 2021....
HORIBA announces its participation in a new consortium formed to accelerate the development of process analytical technologies (PAT) in cell and gene therapy manufacturing. HORIBA’s new A-TEEM™ Molecular Fingerprinting technology has shown great promise for fast QC/QA of complex biological systems and is a core technology being assessed for reducing batch failures and manufacturing costs, to enable faster time to market....
108Labs, a biotechnology and software company with a mission to invent disruptive cellular agriculture projects, has announced their focus on building and programming the world’s first autonomous Cellufacturing® facility and artificial intelligence platform for the production of cell-cultured human milk, in the birthplace of biosynthetic human milk, Hillsborough, North Carolina....
Leading Drug Discovery Contract Research Organisation Sygnature Discovery has announced the set-up of a state-of-the-art Early Candidate Developability Screening Group. Located at its headquarters in Nottingham, UK, the new service line will expand on the company’s offerings to customers by bridging into formal preclinical drug development and paving the way for clinical trials...
The Native Antigen Company, part of LGC Clinical Diagnostics and one of the world’s leading suppliers of reagents that enables research into diagnostics and vaccines for emerging and endemic infectious diseases, won ‘The Best COVID-19 Responder’ at OBN 2020 Awards. The award recognises the Company’s outstanding contribution to the fight against COVID-19....
Glasgow-based R-Biopharm Rhône (RBR), a business which manufactures and distributes test kits for the analysis of foodstuffs for a diverse range of constituents and potential contaminants, has joined the elite ranks of UK businesses accredited with the Investors in People (IIP) Platinum award. The company, employing 60 people at its West of Scotland Science Park base in the north west of the city, is one of the UK’s most successful exporters in its field...
Thermo Fisher Scientific, the world leader in serving science, and the University of Sheffield, a leading institution with a global reputation for research excellence, have joined forces to develop advanced end-to-end workflows for the characterization and monitoring of complex oligonucleotide and mRNA products. This collaboration brings together the University of Sheffield’s extensive research expertise and Thermo Fisher’s cutting-edge sample preparation, liquid chromatography....
INTEGRA Biosciences has made significant progress towards its goal of minimizing its ecological footprint with the installation of new photovoltaic systems at the company’s US facilities in Hudson, NH. These systems will provide 77 percent of the total energy requirement for both the company’s US headquarters and production center, saving as much CO2 as 2900 cars or 2300 single-family homes produce in the USA each year....
As a project company of Xlife Sciences AG (XLS DE), inflamed pharma GmbH has developed a revolutionary and holistic therapeutic approach to treat both SARS-CoV-2 and flu viruses. The patented active substance ProcCluster(R) reduces the viral load by 90% and acts against infection-related inflammatory processes without developing a resistance. It is already used on humans...
Thermo Fisher Scientific, the world leader in serving science, and Newomics, a commercial-stage biotechnology company, are collaborating to develop a novel native liquid chromatography-mass spectrometry (LC−MS) platform to support various LC−MS applications. This agreement utilizes Newomics’ experience in creating innovative and integrative platforms and solutions for precision medicine and Thermo Fisher’s cutting-edge LC-MS systems...
Largest reported organ-on-a-chip screen ever performed on a 3D angiogenesis assay. MIMETAS, the global leader in human-relevant organ-on-a-chip models, has just opened their Phenotypic Screening Center. The center facilitates large-scale screening campaigns on Organ-on-a-Chip models, a powerful technology that improves the human physiological relevance of cultured tissues by utilizing microfluidic techniques....
Aptamer Group Limited, the developer of Optimer™ Therapeutics, and PinotBio (Gyeonggi-do, Korea), a clinical-stage oncology-focused biotechnology company, have entered into a strategic collaboration agreement. The agreement is to develop Optimer-drug conjugates for targeted drug delivery combining Aptamer Group’s Optimer technology with PinotBio’s technology using the chemotherapeutic FL-118 compound with specific linker....
Avacta Group plc the developer of diagnostics and innovative cancer therapies based on its proprietary Affimer® and pre|CISION™ platforms, is pleased to announce that the MHRA has confirmed registration of Avacta’s AffiDX® SARS-CoV-2 antigen lateral flow test allowing the Company to place the product on the market in the UK for professional use...
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has announced that it has entered into an agreement with Thermo Fisher Scientific for fill/finish sterile manufacturing services and supply packaging for Moderna’s COVID-19 vaccine. Under the terms of the agreement, Thermo Fisher’s commercial manufacturing site in Greenville, North Carolina will be used for aseptic fill/finish, labeling and packaging...
e-MSB 2021 has partnered with Virtual Creative Studios to provide an immersive conference experience that mimics the collegial atmosphere of in-person MSB meetings. The program will deliver strong scientific content with opportunities for engagement and building connections. The program will be packed with four full days of invited and contributed talks, general and parallel sessions with heavy focus on live Q&A by world renowned experts...
While the cultured meat industry is gaining momentum, scaling up the production process and reducing the cost remain key challenges. The primary focus of the collaboration between Merck and the two universities will be the development of next generation, scalable bioreactor designs that can support meat and seafood manufacture on a commercial scale....
Malvern Panalytical was delighted to welcome His Royal Highness The Earl of Wessex to its Malvern, Worcestershire, headquarters. Malvern Panalytical was selected for the Royal visit, amongst a small number of other Worcestershire businesses, primarily because of its scientific and technical contribution to the development of medicines and vaccines to treat and prevent COVID-19...
SP Scientific Products (SP) has announced one of the world’s largest simultaneous installations of commercial lyophilizers for use in the production of diagnostic tests. The order, for SP lyophilizers, was made last year by a leading global healthcare company in response to the need for an increase in SARS-CoV-2 testing. With the urgency of the pandemic and requirement for speed, SP was able to complete the delivery of 16 freeze dryers – including manufacturing, testing, and installation - in just four months...
To meet the high demand for lipids, a key component of mRNA-based vaccines and therapeutics, Merck, a leading science and technology company, has launched a new, high-purity synthetic cholesterol product, nine months ahead of schedule. “Tapping into two decades’ experience of developing and manufacturing high-quality lipids, we designed a proprietary process to bring our new SAFC® synthetic cholesterol product to market nearly a year early,” said Andrew Bulpin...
Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Samsung Biologics, a leading global CDMO providing a fully integrated end-to-end contract development and manufacturing service, today announced a Manufacturing Services and Supply Agreement in which Samsung Biologics will provide large scale, commercial fill-finish manufacturing for mRNA-1273, Moderna’s COVID-19 vaccine....
Scientific Laboratory Supplies (SLS) has recently been accredited as a Living Wage Employer. The Living Wage commitment will see everyone working at SLS receive a minimum hourly wage of £9.50 in the UK, or £10.85 in London. Both rates are significantly higher than the government minimum for over 25s, which currently stands at £8.72 per hour...
A shortlist of eye-catching images and videos has been drawn up for the RMS Scientific Imaging Competition – featuring as part of mmc2021. As a ‘sneak preview’, the RMS has put together a collage of all the shortlisted entries across the different categories (excluding video entries) ahead of mmc2021. The images and videos will be uploaded to an online gallery available to view from the start of the event...
In 2021, Eppendorf AG, the Hamburg life sciences company, is presenting its highly prestigious research prize for the 26th time. The independent Eppendorf Award Jury chaired by Prof. Reinhard Jahn announced Dr. Tanmay Bharat, Sir William Dunn School of Pathology, University of Oxford, United Kingdom as the winner of the Eppendorf Award for European Investigators 2021....
HORIBA announces its participation in a new consortium formed to accelerate the development of process analytical technologies (PAT) in cell and gene therapy manufacturing. HORIBA’s new A-TEEM™ Molecular Fingerprinting technology has shown great promise for fast QC/QA of complex biological systems and is a core technology being assessed for reducing batch failures and manufacturing costs, to enable faster time to market....
108Labs, a biotechnology and software company with a mission to invent disruptive cellular agriculture projects, has announced their focus on building and programming the world’s first autonomous Cellufacturing® facility and artificial intelligence platform for the production of cell-cultured human milk, in the birthplace of biosynthetic human milk, Hillsborough, North Carolina....
Leading Drug Discovery Contract Research Organisation Sygnature Discovery has announced the set-up of a state-of-the-art Early Candidate Developability Screening Group. Located at its headquarters in Nottingham, UK, the new service line will expand on the company’s offerings to customers by bridging into formal preclinical drug development and paving the way for clinical trials...
The Native Antigen Company, part of LGC Clinical Diagnostics and one of the world’s leading suppliers of reagents that enables research into diagnostics and vaccines for emerging and endemic infectious diseases, won ‘The Best COVID-19 Responder’ at OBN 2020 Awards. The award recognises the Company’s outstanding contribution to the fight against COVID-19....
Glasgow-based R-Biopharm Rhône (RBR), a business which manufactures and distributes test kits for the analysis of foodstuffs for a diverse range of constituents and potential contaminants, has joined the elite ranks of UK businesses accredited with the Investors in People (IIP) Platinum award. The company, employing 60 people at its West of Scotland Science Park base in the north west of the city, is one of the UK’s most successful exporters in its field...
Thermo Fisher Scientific, the world leader in serving science, and the University of Sheffield, a leading institution with a global reputation for research excellence, have joined forces to develop advanced end-to-end workflows for the characterization and monitoring of complex oligonucleotide and mRNA products. This collaboration brings together the University of Sheffield’s extensive research expertise and Thermo Fisher’s cutting-edge sample preparation, liquid chromatography....
INTEGRA Biosciences has made significant progress towards its goal of minimizing its ecological footprint with the installation of new photovoltaic systems at the company’s US facilities in Hudson, NH. These systems will provide 77 percent of the total energy requirement for both the company’s US headquarters and production center, saving as much CO2 as 2900 cars or 2300 single-family homes produce in the USA each year....
As a project company of Xlife Sciences AG (XLS DE), inflamed pharma GmbH has developed a revolutionary and holistic therapeutic approach to treat both SARS-CoV-2 and flu viruses. The patented active substance ProcCluster(R) reduces the viral load by 90% and acts against infection-related inflammatory processes without developing a resistance. It is already used on humans...
Thermo Fisher Scientific, the world leader in serving science, and Newomics, a commercial-stage biotechnology company, are collaborating to develop a novel native liquid chromatography-mass spectrometry (LC−MS) platform to support various LC−MS applications. This agreement utilizes Newomics’ experience in creating innovative and integrative platforms and solutions for precision medicine and Thermo Fisher’s cutting-edge LC-MS systems...
Largest reported organ-on-a-chip screen ever performed on a 3D angiogenesis assay. MIMETAS, the global leader in human-relevant organ-on-a-chip models, has just opened their Phenotypic Screening Center. The center facilitates large-scale screening campaigns on Organ-on-a-Chip models, a powerful technology that improves the human physiological relevance of cultured tissues by utilizing microfluidic techniques....
Aptamer Group Limited, the developer of Optimer™ Therapeutics, and PinotBio (Gyeonggi-do, Korea), a clinical-stage oncology-focused biotechnology company, have entered into a strategic collaboration agreement. The agreement is to develop Optimer-drug conjugates for targeted drug delivery combining Aptamer Group’s Optimer technology with PinotBio’s technology using the chemotherapeutic FL-118 compound with specific linker....
Avacta Group plc the developer of diagnostics and innovative cancer therapies based on its proprietary Affimer® and pre|CISION™ platforms, is pleased to announce that the MHRA has confirmed registration of Avacta’s AffiDX® SARS-CoV-2 antigen lateral flow test allowing the Company to place the product on the market in the UK for professional use...
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has announced that it has entered into an agreement with Thermo Fisher Scientific for fill/finish sterile manufacturing services and supply packaging for Moderna’s COVID-19 vaccine. Under the terms of the agreement, Thermo Fisher’s commercial manufacturing site in Greenville, North Carolina will be used for aseptic fill/finish, labeling and packaging...
e-MSB 2021 has partnered with Virtual Creative Studios to provide an immersive conference experience that mimics the collegial atmosphere of in-person MSB meetings. The program will deliver strong scientific content with opportunities for engagement and building connections. The program will be packed with four full days of invited and contributed talks, general and parallel sessions with heavy focus on live Q&A by world renowned experts...
While the cultured meat industry is gaining momentum, scaling up the production process and reducing the cost remain key challenges. The primary focus of the collaboration between Merck and the two universities will be the development of next generation, scalable bioreactor designs that can support meat and seafood manufacture on a commercial scale....
Malvern Panalytical was delighted to welcome His Royal Highness The Earl of Wessex to its Malvern, Worcestershire, headquarters. Malvern Panalytical was selected for the Royal visit, amongst a small number of other Worcestershire businesses, primarily because of its scientific and technical contribution to the development of medicines and vaccines to treat and prevent COVID-19...
SP Scientific Products (SP) has announced one of the world’s largest simultaneous installations of commercial lyophilizers for use in the production of diagnostic tests. The order, for SP lyophilizers, was made last year by a leading global healthcare company in response to the need for an increase in SARS-CoV-2 testing. With the urgency of the pandemic and requirement for speed, SP was able to complete the delivery of 16 freeze dryers – including manufacturing, testing, and installation - in just four months...
To meet the high demand for lipids, a key component of mRNA-based vaccines and therapeutics, Merck, a leading science and technology company, has launched a new, high-purity synthetic cholesterol product, nine months ahead of schedule. “Tapping into two decades’ experience of developing and manufacturing high-quality lipids, we designed a proprietary process to bring our new SAFC® synthetic cholesterol product to market nearly a year early,” said Andrew Bulpin...
Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Samsung Biologics, a leading global CDMO providing a fully integrated end-to-end contract development and manufacturing service, today announced a Manufacturing Services and Supply Agreement in which Samsung Biologics will provide large scale, commercial fill-finish manufacturing for mRNA-1273, Moderna’s COVID-19 vaccine....